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In Duchenne muscular dystrophy (DMD) the assessment of diaphragmatic function is cru-
cial because respiratory muscle weakness can cause respiratory failure. We aimed to nonin-
vasively assess diaphragmatic function in DMD by measuring diaphragmatic thickness by
ultrasonography, under the hypothesis that the progressive decrease of lung function is
related to alterations of diaphragmatic thickness.
Methods
Forty-four DMD patients and thirteen healthy controls were enrolled and subdivided into
three age groups. Diaphragmatic thickness was measured during quiet breathing, inspira-
tory capacity, maximal inspiratory pressure and expiratory pressure maneuvers.
Results
In DMD, absolute values of diaphragmatic thickness were significantly lower than in controls
in the majority of the manoeuvers and diaphragmatic thickness significantly decreased with
age at end-expiration, remaining constant at end-inspiration and during maximal inspiratory
pressure maneuvers. Comparing to controls, absolute values of diaphragmatic thickness
and diaphragmatic thickness variations were significantly lower (p<0.001), with the excep-
tion of quiet breathing and maximal expiratory pressure maneuvers in the youngest DMD.
During maximal inspiratory pressure maneuver, variation of diaphragmatic thickness was
not significantly different in the all groups, nevertheless maximal inspiratory pressure
decreases with age.
Conclusions
The diaphragm is prone to pseudo-hypertrophy in the youngest DMD, and to progressive
atrophy in middle-age and oldest DMD. Diaphragm impairment could be expressed as a dis-
sociation between muscle drive and muscle developed force. Ultrasonography could be
used as a noninvasive method to assess progressive diaphragmatic weakness.







Citation: Laviola M, Priori R, D’Angelo MG, Aliverti
A (2018) Assessment of diaphragmatic thickness
by ultrasonography in Duchenne muscular
dystrophy (DMD) patients. PLoS ONE 13(7):
e0200582. https://doi.org/10.1371/journal.
pone.0200582
Editor: Atsushi Asakura, University of Minnesota
Medical Center, UNITED STATES
Received: November 27, 2017
Accepted: July 1, 2018
Published: July 26, 2018
Copyright: © 2018 Laviola et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was supported by Fondo DMD
“Amici di Emanuele” Onlus.
Competing interests: The authors have declared
that no competing interests exist.
Introduction
Respiratory failure is the commonest cause of death in Duchenne muscular dystrophy (DMD)
and it is caused by progressive respiratory muscle weakness, which tends to develop only at the
pre-terminal stage of the illness [1]. The assessment of diaphragmatic function, as the main
inspiratory muscle, thus results to be of extreme importance, but the techniques traditionally
employed to assess diaphragmatic weakness or paralysis in DMD, such as transdiaphragmatic
pressure, EMG, fluoroscopy and plethysmography are either highly invasive, associated with
radiation or very complex.
A hallmark sign of DMD is the progressive atrophy of the skeletal muscles, together with
the so-called ‘pseudo-hypertrophy’, which is caused by replacement or infiltration of muscles
by fatty and/or collagenous tissue and is present in specific muscle compartments. This infor-
mation regarding the structural alteration of the diaphragm comes from an autopsy study per-
formed on mdx mice [2], due to the inherent difficulties in performing in-vivo studies in
humans. Computed tomography (CT) and Magnetic Resonance Imaging (MRI) provide good
resolution and allow to obtain a detailed 3-D reconstruction of the shape of the diaphragm [3–
5]. However, the clinical use of volumetric techniques based on CT and MRI is still limited for
several reasons, namely the ability to analyse only horizontal postures, the high costs, the radia-
tion exposure in CT, and the prolonged timing required for data acquisition in MRI. Ultraso-
nography (US) has proven to be useful for the study of anatomical characteristics of many
muscle groups [6–9] and has been proposed as a possible alternative to study both diaphrag-
matic structure and function, namely diaphragmatic thickness [9–11], thickening ratio in
adults [12] and children [13] mechanically ventilated and excursion [14, 15].
The aim of this study is to noninvasively assess diaphragmatic function in DMD patients by
measuring diaphragmatic thickness (DT) by US, under the hypothesis that the progressive
decrease of lung function is related to alterations of DT.
Materials and methods
Subjects
A total of 57 subjects were enrolled for the study, 44 DMD patients and 13 age-matched
healthy controls. DMD patients were selected according to the following inclusion criteria:
free of non-DMD respiratory complications, older than 6 years and able to perform respiratory
maneuvers. The diagnosis of DMD was made on the basis of traditional criteria, i.e. progres-
sive muscular deficit resulting in severe motor disability, increased muscle plasma enzymes,
muscle biopsy identifying muscular degeneration and absence of dystrophin, alterations in the
DMD gene (deletions, duplications or point mutations).
DMD patients and controls were subdivided into three groups according to age: <14 yrs
(4 still ambulant), between 14 and 18 yrs and >18 yrs old. This subdivision of our patients
is related to disease stages according to published natural history data (< 14 yrs: loss of
ambulation and initial respiratory function decline; 14–18 yrs, respiratory function alter-
ation associated to global moderate-severe muscular involment; < 18 yrs advanced stage of
the disease, need of ventilator or cough device support) [16, 17]. Control subjects were
selected based on the following criteria: no history of smoking; no previous lung, orthopedic
or rheumatologic disease or spinal deformities that compromised respiratory system
mechanics; not having undergone a specific sporting training. All subjects (or parents of the
patient in the case of children) signed a written informed consent form. The study was
approved by the Ethical Committee of the IRCCS ‘‘E. Medea” Institute according to the dec-
laration of Helsinki.
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Pulmonary function tests and respiratory muscle assessment
Forty-two DMD patients underwent pulmonary function tests. Measurements of forced vital
capacity (FVC), forced expiratory volume in 1s (FEV1) and peak expiratory flow (PEF) were
performed in a seated position with a flow meter attached to a flanged rubber mouthpiece,
with the nose occluded (Vmax series 22; SensorMedics, Yorba Linda, CA, USA). Subdivisions
of lung volumes (functional residual capacity (FRC), residual volume (RV) and total lung
capacity (TLC)) were measured using the nitrogen washout technique (Vmax series 22; Sen-
sorMedics). Nocturnal oxygen saturation measurements by pulse oximetry (Nonin 8500;
Nonin, Minneapolis, MN, USA) were also performed in all patients. Maximal respiratory pres-
sures were measured at the mouth (MicroRPM; Micro Medical Ltd., Rochester, England) in
seated position. Maximal expiratory pressure (MEP) and maximal inspiratory pressure (MIP)
were performed starting respectively from TLC and RV and the effort was maintained for at
least one second. The best MEP and MIP values in two or more attempts were chosen.
Ultrasound assessment of diaphragmatic thickness
In all subjects, DT was measured in supine position by ultrasonography during 1 minute of
quiet breathing (QB), 2 inspiratory capacity (IC) maneuvers (full inspiration from Functional
Residual Capacity, FRC, to Total Lung Capacity, TLC), 2 maximal inspiratory pressure (MIP)
maneuvers, performed at residual volume (RV) and 2 maximal expiratory pressure (MEP)
maneuvers, performed at TLC. A standard echograph (Aquila Esaote, Genoa, Italy) equipped
with an 8 MHz linear probe was used. The probe was placed on the lateral ribcage in the right
9th or 10th intercostal space between the midclavicular and anterior axillary lines and it was
firmly held in this position during each maneuver. High resolution B-mode allowed to visual-
ize the diaphragm, identified as the region between two clear bright parallel lines, namely the
pleural and peritoneal membranes. Flow and pressure were measured at the mouth respec-
tively by a pneumotacograph (3813, Hans Rudolph, Kansas City, Missouri), connected to a
low range pressure sensor (RCEM010DB, Sensortechnics, Munich, Germany), and a high
range pressure transducer (RCEM250DB, Sensortechnics, Munich, Germany).
All ultrasonographic images, coming from the echograph, and flow and pressure analogic
signals were recorded synchronously at a sampling rate of 10 and 200 Hz, respectively, by a
custom-designed Labview1 software connected to an A/D board (National Instruments USB-
6008 DAQ) (Fig 1). Images were saved into series of raw bitmap files.
Image and data analysis
Processing of images and signals was performed offline by a custom software developed in
Matlab1. The software allowed to select specific instants on pressure or flow tracings and to
load the corresponding image, i.e. the saved image corresponding to the closest sample to the
instant of interest. More specifically, we considered zero-flow points during quiet breathing
(i.e., end expiration, EE, and end-inspiration, EI) and the instant at maximal inspiration dur-
ing an inspiratory capacity maneuver, chosen as the maximal value on the time-integrated
flow signal (here below called TLC). The points in which the pressure reached the minimum
value during a maximal inspiratory pressure (MIP) maneuver and the maximum value during
a maximal expiratory pressure (MEP) maneuver were also selected for analysis and called
MIPUS,max and MEPUS,max, respectively.
Once the time-instant of interest was selected, the software performed the following
analysis:
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1. automatic extraction of the two curves corresponding to the edge of the pleural and the bot-
tom of the peritoneal membrane of the diaphragm, on the basis of a region growing algo-
rithm and a set of morphological operators applied to the US image [18, 19];
2. calculation of DT, as the average distance between the two curves extracted on the US
image;
3. saving of the values of volume variations (obtained by integration in time of flow signals)
during QB and IC maneuvers, and of pressure, during MIP and MEP maneuvers.
The shortest distance that could be resolved between the two lines using this approach was
0.5 mm, a value significantly lower than the thickness of the relaxed diaphragm.
On each subject, DT was assessed by considering the average value of five breaths (EE and
EI), and between 2 and 4 acceptable IC, MIP and MEP manoeuvers.
Three different measurements of maximal inspiratory pressure (MIP) and maximal expira-
tory pressure (MEP) expressed in cmH2O were recorded:
1. MIPUS and MEPUS: pressures measured during MIP and MEP manoeuvers performed in
supine position, and recorded during ultrasound measurements, occurring at the time
when diaphragmatic thickness was obtained on US images;
2. MIPUS,max and MEPUS,max: maximal pressures recorded during MIP and MEP manoeuvers,
in supine position during ultrasound measurements;
3. MIPseat and MEPseat: maximal pressures measured during MIP and MEP manoeuvers in
seated position, performed on the same day of ultrasound measurements.
For the calculation of the predicted values of MIP and MEP, the following equations, valid
for boys, were used: MIPpred = [2.58 + age x 0.39] [20] and MEPpred = [35+ (5.5 x age)] [21].
Statistical analysis
The sample size calculation was performed considering diaphragm thickness data obtained in
a previous study [11]. We considered a significance level of 95% (p< .05), 80% power, a
Fig 1. Diaphragm B-mode ultrasound and acquisition software front panel. (A) Diaphragm thickness (DT) at maximal inspiratory pressure
maneuver in supine position measured as the distance between pleural and peritoneal membranes of the diaphragm colored in red; (B) front panel of
the Labview software for the synchronously recording of ultrasonographic images and flow and pressure signals.
https://doi.org/10.1371/journal.pone.0200582.g001
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standard deviation of 0.15 mm and a minimum calculated detected difference of 0.2 mm. The
sample size was estimated as 10 subjects according to these data.
To evaluate healthy controls and DMD patients’characteristics and DMD patients’ pulmo-
nary function tests among tree groups (gathered by age), a one-way analysis of variance
(ANOVA) was performed; while to compare within each group MIPUS, MIPUSmax MIPseat and
MIP%pred a one way repeated measures was applied.
To determine the difference in DT between overall DMD patients and healthy controls a
two-way ANOVA was performed, using disease (healthy controls and DMD) and maneuver
(EE, EI, TLC, MEP and MIP) as independent factors. To evaluate the difference in DT among
all three DMD groups and controls, a two-way ANOVA was performed, at EE, EI and MIP,
using disease and age as independent factors.
Parametric tests were performed when variables were normally distributed, otherwise non-
parametric tests were used. For multiple comparisons post hoc tests based on Holm-Sidak
method were used. Sample sizes were calculated during quiet breathing and maneuvers in
both healthy controls and DMD patients, by choosing a value of 0.05 and a desired power of
0.80. Differences were considered as significant with p value <0.05. Statistical analysis were
performed using the software SigmaStat 3.5.
Results
The anthropometric characteristics of DMD population are reported in Table 1.
Pulmonary function
The results of pulmonary function tests of DMD patients are shown as average values as a
function of the different age groups in Table 1. A strongly significant progressive reduction of
predicted FVC, FEV1, PEF (p<0.001) and TLC (p = 0.004) with age was observed. Similarly in
the predicted values of MIP (p = 0.001) and MEP (p = 0.003) a marked decrease was observed,
while MEP slightly decreases (p = 0.023). Nocturnal time spent in desaturation significantly
increased with age (p<0.002)
Maximal pressures
Table 2 shows all values of MIPUS, MEPUS, MIPUS-max, MEPUS-max, MIPseat and MEPseat.
For the majority of MIP measurements no significant differences were found (just in the
age group 14–18 yrs, the values in seated position were significantly lower than in supine),
whereas for MEP measurements the values obtained in the seated position were significantly
higher than those in supine.
Diaphragmatic thickness
As shown in Fig 2, the values of diaphragmatic thickness in all DMD patients were signifi-
cantly lower than healthy controls in each considered conditions, apart from EE.
In Fig 3, all values of DT at EE, EI and MIP are shown for healthy controls (white circles)
and for DMD patients (black circles) for the three age groups. In healthy controls diaphrag-
matic thickness significantly increased with age. Conversely, in DMD patients diaphragmatic
thickness significantly decreased with age at end-expiration and it remained constant at end-
inspiration and during MIP manoeuver. In the age groups 14–18 and >18 yrs, DT was signifi-
cantly lower in DMD patients than healthy controls for all considered conditions. The com-
plete set of average values of DT at EE, EI, TLC and during MIP and MEP for the different age
groups of healthy controls and DMD patients is reported in Table 3. In the same table, also DT
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variations, expressed as percentage DT variations between TLC and EE and MIP and EE, are
reported. Comparing healthy controls and DMD patients, all DT and DT variations were sig-
nificantly different, with the only exception of DT values at EE and EI during quiet breathing
and MEP in the age group <14 yrs.
Relationship between DT and maximal pressures and DT and vital capacity
The existing relationship between diaphragmatic thickness and MIP%pred and diaphragmatic
thickness and FVC%pred in DMD patients is reported in Fig 4 for both individual data
Table 1. Duchenne muscular dystrophy (DMD) patients’ characteristics and pulmonary function test results.
All age<14yrs age14-18yrs age>18yrs p-value
Healthy Controls
n 13 5 3 5
Age (yrs) 15.2±6.5 8.6±2.1 14.3±2.5˚˚˚ 22.4±1.1˚˚˚,~~~ <0.001
Height (cm) 162.0±21 134.5±3.3 175.3±4.5˚˚˚ 176.1±5.1˚˚˚ <0.001
Weight (Kg) 55.5±23 28.8±2.5 62.3±9.7˚ 72.7±16.6˚˚˚ 0.001
BMI (Kg/m2) 20.2±4.3 16.3.8±2.3 20.2±2.1 23.3±4.1˚ 0.028
DMD Patients
n 44 13 15 16
Age (yrs) 16.3±4.6 11.0±1.53 15.53±1.36˚˚˚ 21.50±1.97˚˚˚,~~~ <0.001
Height (cm) 155.4±16 134.9±8.9 159.9±10.2 ˚˚˚ 167.8±6.1 ˚˚˚,~~ <0.001
Weight (Kg) 54.2±18.6 40.2±12.4 62.0±17.8˚˚ 58.5±17.7˚˚ 0.004
BMI (Kg/m2) 22.2±5.1 21.7±5.2 23.9±4.6 20.7±5.3 NS
Spirometry
n 42 11 15 16
FVC (%pred) 53.4±24.6 78.3±16.9 55.2±22.9˚˚ 34.5±11.8˚˚˚,~~ <0.001
FEV1 (%pred) 51.8±28.5 84.4±22.3 49.1±22.9˚˚˚ 31.9±13.6˚˚˚,~ <0.001
FEV1/FVC (%) 77.7±20.1 82.1±26.6 74.9±21.3 77.2±13.6 NS
PEF (%pred) 44.0±24.2 65.3±28.7 44.6±17.1˚ 28.8±13.9˚˚˚,~ <0.001
Respiratory muscles pressures
n 39 10 15 14
MIP (cmH2O) 31.4±17.8 35.0±12.9 35.9±23.0 23.9±12.3 NS
MIP%pred 37.2±23.8 52.4±22.3 41.4±26.2 21.8±10.7˚˚˚ 0.001
MEP (cmH2O) 31.0±13.6 40.9±11.4 30.0±14.5 25.2±10.6˚ 0.023
MEP%pred 25.2±15.9 39.7±19.5 24.8±11.8 15.3±7.6˚˚ 0.003
Lung Volume
n 42 11 15 16
TLC (%pred) 63.9±24.9 81.2±19.1 65.5±21.8 49.7±23.8˚˚ 0.004
RV (%pred) 102.1±51.9 107.6±61.2 98.7±40.9 107.6±61.2 NS
FRC,N2 (%pred) 72.4±29.7 81.1±31.2 69.2±25.0 69.1±33.3 NS
Sp,O2%
n 42 12 15 15
100–95 91.7±15.8 99.7±0.9 89.9±19.2˚ 88.0 ±16.9˚˚ 0.002
94–90 8.0±15.8 0.3±0.9 9.5±19.2˚ 12.5±17.0˚˚ 0.002
<90 0.2±0.8 0.0±0.0 0.5±1.4 0.1±0.35 NS
(n: available data; NS: nonsignificant, Sp,O2%: percentage of the night-time spent with Sp,O2 in different ranges 95–100%, 90–94%, <90%). Data are presented as
mean±SD.
p-values (one-way ANOVA): ˚,˚˚,˚˚˚,: p<0.05, p<0.01, p<0.001 vs age<14; ~,~~~, ~~~: p<0.05, p<0.01, p<0.001 vs age 1418
https://doi.org/10.1371/journal.pone.0200582.t001
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(Fig 4A and 4C) and averaged over the different age groups (Fig 4B and 4D). Diaphragmatic
thickness at EE was slightly correlated (r2 = 0.1980 and p = 0.0040) with MIP%pred whereas
diaphragmatic thickness measured at MIP did not present any correlation. The age group >18
yrs was characterized by the lowest MIP%pred, the lowest averaged value of DT at EE and an
average value of DT at MIP similar to those measured in the other age groups.
Table 2. Values of pressure during MIP and expiratory MEP maneuvers.
Pressure (cmH2O) Controls subjects DMD patients
age<14yrs age14-18yrs age>18yrs age<14yrs age14-18yrs age>18yrs
MIPUS 33.6±17.6 67.1±50.3 75.9±22.2 27.4±19.1 42.0±18.0 22.9±12.1
MIPUS,max 39.3±23.3 77.6±58.9 83.4±18.4 30.8±19.6 43.4±10.6 23.9±10.7
MIPseat N.A N.A N.A 35.4±12.9 35.9±23.0$ 23.9±12.3
MEPUS 25.3±16.1 58.7±11.6 78.7±18.8 22.2±9.3 18.8±11.3 17.7±9
MEPUS,max 30.7±19.0 63.2±8.7 85.9±18.4## 23.6±8.9 20.9±12.1# 20.7±8.9
MEPseat N.A N.A N.A 40.9±11.4$ $ $, ### 30.0±14.5## 25.2±10.6$, ###
Data are expressed in cmH2O and presented as mean±SD. MIPUS and MEPUS: pressure values correspondent to the instant in which the US image was chosen in order
to calculate diaphragmatic thickness (supine position); MIPUS,max and MEPUS,max: maximal pressure values measured during the maneuver in which the US images
were recorded in order to calculate diaphragmatic thickness (supine position); MIPseat and MEPseat: maximal pressures recorded by a commercial respiratory pressure
meter (seated position). p-values (one-way RM ANOVA): $,$ $ $: p<0.05, p<0.001 vs MIPUS,max or MEPUS,max; #, ##, ###: p<0.05, p<0.01, p<0.001, vs MEPUS;
https://doi.org/10.1371/journal.pone.0200582.t002
Fig 2. Average data of diaphragmatic thickness (DT) per overall groups. Values of DT are reported at end-
expiration (EE) and end-inspiration (EI) during quiet breathing, at total lung capacity (TLC) during full inspirations
and during maximal inspiratory (MIP) and expiratory (MEP) pressure manoeuvers in healthy controls (white bars)
and DMD patients (black bars). (,: p<0.05, p<0.001 vs healthy controls).
https://doi.org/10.1371/journal.pone.0200582.g002
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Diaphragmatic thickness at EE did not present any correlation with FVC%pred, whereas a
slightly (r2 = 0.1243, p = 0.0299) correlation was found between diaphragmatic thickness at
TLC and FVC%pred.
Discussion
The first finding of the present study is that in our overall DMD population, diaphragmatic
thickness is significantly lower than in controls in the majority of the analyzed conditions,
Fig 3. Diaphragmatic thickness (DT) per age group. Values of DT are reported at end-expiration (EE), end-inspiration (EI) and during maximal
inspiratory pressure (MIP) maneuvers, in healthy controls (white circles) and in DMD patients (black circles) grouped by age (,,: p<0.05, p<0.01,
p<0.001 vs healthy controls, ˚˚,˚˚˚: p<0.01, p<0.001 vs age<14).
https://doi.org/10.1371/journal.pone.0200582.g003
Table 3. Complete set of average values of diaphragmatic thickness (DT) in healthy and in DMD patients.
Diaphragmatic Thickness (DT) Control Subjects DMD patients
age<14yrs age14-18yrs age>18yrs age<14yrs age14-18yrs age>18yrs p-value (control vs DMD)
DT at End-Expiration (EE), mm 1.6±0.2 1.9±0.3 2.1±0.3˚˚˚ 1.7±0.2 1.5±0.1 1.5±0.2,˚˚ <0.001
DT at End-Inspiration (EI), mm 2.0±0.2 2.4±0.5 2.5±0.4˚˚˚ 1.9±0.2 1.8±0.2 1.7±0.2 <0.001
DT at TLC, mm 2.8±0.4 3.3±1.2 3.5±0.6 2.1±0.6 2.2±0.2 2.3±0.3 <0.001
DT at MIP, mm 2.8±0.5 3.5±0.6˚˚ 3.9±0.3˚˚˚ 2.3±0.3 2.4±0.3 2.4±0.26 <0.001
DT at MEP, mm 1.2±0.4 1.7±0.2˚˚˚ 1.4±0.3 1.2±0.1 1.2±0.1 1.1±0.2 0.004
ΔDTTLC-EE% 77.2±23.5 68.1±35.6 67.8±36.5 43.2±18.3 48.6±19.4 43.2±15.5 <0.001
ΔDTMIP-EE% 73.8±25.1 79.3±17.0 85.7±13.7 43.6±26.3 59.4±24.5 56.3±13.4 <0.001
TF% 21.3±12.1 20.8±8.5 23.9±9.4 18.4±10.1 20.4±9.5 15.5±4.9 NS
TRTLC 1.7±0.4 1.7±0.4 1.8±0.2 1.6±0.3 1.5±0.2 1.2±0.5˚˚ 0.023
TRMIP 1.9±0.1 1.8±0.2 1.7±0.3 1.4±0.6 1.6±0.2 1.4±0.3 0.011
EE, end-expiration, EI, end-inspiration, TLC, full inspirations at total lung capacity, MIP maximal inspiratory pressure, MEP, maximal expiratory pressure;
ΔDTTLC-EE% percentage variation of diaphragmatic thickness between TLC and EE: (diaphragm thickness at TLC- diaphragm thickness at EE) /diaphragm thickness
at EE; ΔDTMIP-EE% percentage variation of diaphragmatic thickness between MIP and EE: (diaphragm thickness at MIP- diaphragm thickness at EE) /diaphragm
thickness at EE; TF: thickness fraction: (diaphragm thickness at EI- diaphragm thickness at EE) /diaphragm thickness at EE; TRTLC, thickening ratio: diaphragm
thickness at TLC/diaphragm thickness at EE; TRMIP, thickening ratio: diaphragm thickness at MIP/diaphragm thickness at EE; p-values (two-way ANOVA): ,,:
p<0.05, p<0.01, p<0.001 vs control subjects; ˚˚,˚˚˚: p<0.01, p<0.001 vs age<14yrs; NS: non significant
https://doi.org/10.1371/journal.pone.0200582.t003
Diaphragm thickness by US in DMD patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0200582 July 26, 2018 8 / 13
namely at end-inspiration during quiet breathing, at total lung capacity and at maximal inspi-
ratory and expiratory pressures.
A second finding is that, in the youngest DMD patients, diaphragmatic thickness at rest is
similar to age-matched healthy controls with lower values of MIP, although not statistically sig-
nificant. These results might suggest that the diaphragm is prone to pseudo-hypertrophy, how-
ever, future studies with a higher number of subjects are required to confirm this hypothesis,
possibly using techniques with higher resolution than US. De Bruin et al. [11] described dia-
phragmatic pseudo-hypertrophy in young (10 years old) DMD patients, indicated by an
increased diaphragmatic thickness at end-expiration. It can be hypothesized, therefore, that in
the youngest DMD the diaphragm shows hypertrophy as other skeletal muscles and, similarly,
it is associated to a reduction of the capacity of producing force. In our group of patients, in
fact, we did not find a significant difference in DT between DMD and controls, however, the
Fig 4. Diaphragmatic thickness (DT) related to MIP%pred and FVC%pred in DMD patients. DT at end-expiration (EE) (black circles), during
maximal inspiratory pressure (MIP) maneuvers (white circles) and at total lung capacity (TLC) (white diamonds). A) Single values of DT for all
DMD patients. A linear correlation was found only for DT in the EE condition. B) Mean values ± standard error of DT of the three DMD aged groups
(˚: p<0.05 vs group<14 yrs old; ~: p<0.05 vs 1418yrs); C) Single values of DT for all DMD patients. A linear correlation was found only for DT in the
TLC. D) Mean values ± standard error of DT of the three DMD aged groups (˚˚˚ p<0.001 vs group<14 yrs old).
https://doi.org/10.1371/journal.pone.0200582.g004
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values of DT were lower in DMD compared to healthy controls considering the developed
force (i.e., MIP).
A third relevant finding is that diaphragmatic thickness at end-expiration and end-inspira-
tion was similar to the control group in the youngest (age<14yrs) DMD patients, but signifi-
cantly lower in the middle (14-18yrs) and in the oldest (>18yrs) group of patients. This result
is suggestive of a progressive atrophy of diaphragm muscle. Although no data are available
regarding atrophy of the diaphragm in humans, a recent study performed on a canine (Golden
Retriever) model of muscular dystrophy has shown evidence of morphometric remodeling of
the diaphragm (i.e., loss of sarcomeres in series and increase in muscle stiffness) associated
with rapidly progressive loss of ventilatory capacity after the first year of life [22].
The significance of DT measurements is different depending on the different considered
parameters. Diaphragmatic thickness in the relaxed muscles (i.e. DT at end-expiration during
spontaneous breathing) provides information regarding the total amount of muscle mass.
Measurements of DT alone, however, may not discriminate between a paralyzed or function-
ing diaphragm. In fact, DT may be greater than 2.0 mm if the paralysis occurs and atrophy has
not occurred. On the other hand, DT may be less than 2.0 in some individuals with a function-
ing diaphragm who have generalized muscle wasting or in small individuals [23].
Variation of DT during different manoeuvers (ΔDT), instead, provides information related
to the number of active muscle fibers [23]. More specifically, diaphragmatic thickening during
MIP manoeuver has formerly been shown to be a good indicator of the efficacy of inspiratory
muscle contraction in producing force in normal adults [10]. In our population of both healthy
controls and DMD patients, during MIP the variation of DT relative to rest (ΔDT%) and the
thickness ratio were not significantly different in the different age groups, but lower than con-
trols [11]. Furthermore, in healthy subjects MIP increases with age, while in DMD it decreases
[24–26]. This result, moreover, suggests that diaphragm impairment in DMD could be
expressed as a dissociation between muscle drive and muscle developed force, as recently
shown by Burns et al. [27] in the mouse model of DMD, who found a potentiated neural
motor drive to breathe suggesting compensatory neuroplasticity enhancing respiratory motor
output to the diaphragm. This confirms that diaphragm weakness appears to develop, and to
be more noticeable, at a later stage of the disease [28–32].
The present study has several strengths. Here, we considered a wide range of ages of DMD
patients, including not only young patients, as in the previously performed studies, but also
older ones, with age-matched healthy controls. Diaphragmatic thickness was evaluated during
different maneuvers, such as quiet breathing, full inspiration, MIP and MEP.
Moreover, values of DT in healthy subjects at end-expiration (1.9 ± 0.3 mm) are in agree-
ment with previous studies [10, 18] such as those during MIP maneuver in the oldest group
(3.9 ± 0.3 mm) [10]. Boon et al. [33] reported values of DT at end-expiration higher with
respect to those reported here (3.3±0.1mm versus 1.9±0.3 mm). This discrepancy could be
explained by the fact that those authors studied subject with a mean BMI of 27.9 Kg/m2
whereas in our study the mean BMI was 20.2 Kg/m2. Nevertheless, the lower limit of DT (1.7
mm) and the thickening ratio during a full inspiration were consistent with the values found
in the present study (1.8±0.5 vs 1.7±0.3).
Additionally, ultrasound images were synchronized with flow and pressure signals in order
to calculate DT in the exact correspondence of the selected breath or maneuver. For this pur-
pose, it was developed a dedicated system for simultaneous measurement of echographic
images and respiratory signals (flow and pressure), which enabled a precise assessment of DT
at the different relevant times. It is also important to note that MIP and MEP were measured
not only in the experimental (i.e., supine during US measurements), but also in the clinical
standard (i.e., seated) conditions.
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Limitations of the study include the relative small number of healthy subjects. However, in
our control group the values are very similar to those reported in the literature [34].
Also, DT measurements were performed only in supine position. This was due to difficul-
ties in performing the measurements in other positions, such as the seated position in the
wheelchair. In the seated position it is not-practicable to hold the probe perpendicular to the
right chest wall. Nevertheless, supine position has been shown to be the best posture in order
to show diaphragmatic impairment [30, 35]. In addition, as right hemidiaphragm is easier to
observe than on the left due to its large contact with surface with the liver, we did not perform
measurement at the left side of the diaphragm. Gottesman and Mc Cool [23], however, did not
find any significant difference in DT measurements between the left and right hemidiaphragm.
Lastly, we measured thickness in the costal region only. Thibaud et al. [36], however, showed
by MRI a relative heterogeneity of diaphragm structural alteration in the Golden Retriever
model of muscular dystrophy.
We believe that the study has a number of clinical implications. DT assessment by ultra-
sound has been already validated in healthy subjects [10, 37] and in supine position [9]. More-
over, it represents an inexpensive, noninvasive and easy method, available in all clinical
centers, for assessing the progressive diaphragm involvement in DMD patients, to potentially
be considered as outcome measure in clinical trials.
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